Brief: BD Announces High-Throughput Single-Cell Multiomics Platform
03/02/2023 12:41
Feb 3 (Reuters) - Becton Dickinson and Co BDX.N :
* BD INTRODUCES HIGH-THROUGHPUT SINGLE-CELL MULTIOMICS
PLATFORM TO
EXPAND SCOPE OF SCIENTIFIC DISCOVERY
* BD - NEW BD RHAPSODY HT XPRESS SYSTEM AND OTHER
INNOVATIONS TO
BE UNVEILED AT AGBT
Source text for Eikon: ID:nPnbDHR61a
Further company coverage: BDX.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Becton Dickinson and Co
See all newsCorrected: BDx secures data center power contract from Indonesia's PLN
China's commerce ministry holds meeting with foreign pharmaceutical firms
Brief: Becton Dickinson Euro Finance S.À R.L Files For Euro-Denominated 600 Million 3.855% Notes Offering Due 2033 - SEC Filing
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
Becton Dickinson raises 2026 profit forecast on drug delivery devices demand (updated)